BRPI0919102A2 - non-typhoid salmonella vaccines - Google Patents

non-typhoid salmonella vaccines

Info

Publication number
BRPI0919102A2
BRPI0919102A2 BRPI0919102A BRPI0919102A BRPI0919102A2 BR PI0919102 A2 BRPI0919102 A2 BR PI0919102A2 BR PI0919102 A BRPI0919102 A BR PI0919102A BR PI0919102 A BRPI0919102 A BR PI0919102A BR PI0919102 A2 BRPI0919102 A2 BR PI0919102A2
Authority
BR
Brazil
Prior art keywords
salmonella vaccines
typhoid salmonella
typhoid
vaccines
salmonella
Prior art date
Application number
BRPI0919102A
Other languages
Portuguese (pt)
Inventor
Adam Cunningham
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Birmingham filed Critical Univ Birmingham
Publication of BRPI0919102A2 publication Critical patent/BRPI0919102A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BRPI0919102A 2008-09-09 2009-09-09 non-typhoid salmonella vaccines BRPI0919102A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0816462.6A GB0816462D0 (en) 2008-09-09 2008-09-09 Non-typoidal salmonella vaccines
PCT/GB2009/002159 WO2010029293A1 (en) 2008-09-09 2009-09-09 Non-typhoidal salmonella vaccines

Publications (1)

Publication Number Publication Date
BRPI0919102A2 true BRPI0919102A2 (en) 2015-12-08

Family

ID=39889049

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919102A BRPI0919102A2 (en) 2008-09-09 2009-09-09 non-typhoid salmonella vaccines

Country Status (11)

Country Link
US (1) US20110206717A1 (en)
EP (1) EP2324051B1 (en)
CN (1) CN102209724A (en)
AU (1) AU2009290670B2 (en)
BR (1) BRPI0919102A2 (en)
CA (1) CA2736543A1 (en)
ES (1) ES2617242T3 (en)
GB (1) GB0816462D0 (en)
NZ (1) NZ591738A (en)
WO (1) WO2010029293A1 (en)
ZA (1) ZA201101786B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016012597A (en) * 2014-03-27 2017-04-27 Sambuddha Ghosh Expression of a single chain antibody against salmonella in lactobacillus.
US11123415B2 (en) 2017-08-16 2021-09-21 Ohio State Innovation Foundation Nanoparticle compositions for Salmonella vaccines
CN113563465B (en) * 2021-06-11 2023-02-03 扬州大学 Salmonella PhoN protein antibody and detection method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY126769A (en) * 2000-02-28 2006-10-31 Univ Sains Malaysia Dna sequence encoding the specific and antigenic outer membrane protein of salmonella typhi
CA2626114A1 (en) * 2005-10-28 2007-05-10 University Of Maryland, Baltimore Attenuated salmonella enterica serovar paratyphi a and uses thereof

Also Published As

Publication number Publication date
GB0816462D0 (en) 2008-10-15
AU2009290670A1 (en) 2010-03-18
WO2010029293A1 (en) 2010-03-18
US20110206717A1 (en) 2011-08-25
AU2009290670B2 (en) 2014-09-04
EP2324051B1 (en) 2016-11-23
NZ591738A (en) 2013-05-31
ES2617242T3 (en) 2017-06-15
CA2736543A1 (en) 2010-03-18
CN102209724A (en) 2011-10-05
EP2324051A1 (en) 2011-05-25
ZA201101786B (en) 2012-05-30

Similar Documents

Publication Publication Date Title
NO2020021I1 (en) Brolucizumab
NL300879I2 (en) Alirocumab
BRPI0907376A2 (en) Photobiorretador
DK2342317T3 (en) HANGING-DROP-PLATE
DE602009000234D1 (en) msignals
BRPI0914649A2 (en) Piprazole-quinazolines
DE602008003972D1 (en) Sitzrücklehnungsmechanismus
DE602008003521D1 (en) Sitzrücklehnungsmechanismus
DK2336132T3 (en) MORPHOLINPURINDERIVAT
DK2335031T3 (en) IN-LINE-GAUGE
DE602008003970D1 (en) Strahlstromkalibriersystem
DK2271613T3 (en) Hydroxymethylcyclohexylamines
BRPI0915562A2 (en) tamis improved
BRPI0915442A2 (en) tamis improved
BRPI0907522A2 (en) biarlamides
DE112009001946A5 (en) MOBELAUSZUGSFÜHRUNG
DE602009000488D1 (en) Obstvereinzelvorrichtung
BRPI0907863A2 (en) pyrrolopyrimidinecarboxamides
BRPI0909634A2 (en) 2-aminoquinolines
DE112009000183A5 (en) Sicherheitsvorreiber
BRPI0909637A2 (en) 2-aminoquinolines
DE602009000862D1 (en) Gehwagenbremse
AT507449A3 (en) DÄMMSTOFFBEFESTIGER
DK2344933T3 (en) Uretui
BRPI0921578A2 (en) unitemporal vaccines

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2478 DE 03-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.